Your browser doesn't support javascript.
loading
Modeling glioblastoma heterogeneity as a dynamic network of cell states.
Larsson, Ida; Dalmo, Erika; Elgendy, Ramy; Niklasson, Mia; Doroszko, Milena; Segerman, Anna; Jörnsten, Rebecka; Westermark, Bengt; Nelander, Sven.
Afiliación
  • Larsson I; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Dalmo E; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Elgendy R; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Niklasson M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Doroszko M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Segerman A; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Jörnsten R; Department of Medical Sciences, Cancer Pharmacology and Computational Medicine, Uppsala University Hospital, Uppsala, Sweden.
  • Westermark B; Mathematical Sciences, Chalmers University of Technology, Gothenburg, Sweden.
  • Nelander S; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Mol Syst Biol ; 17(9): e10105, 2021 09.
Article en En | MEDLINE | ID: mdl-34528760
ABSTRACT
Tumor cell heterogeneity is a crucial characteristic of malignant brain tumors and underpins phenomena such as therapy resistance and tumor recurrence. Advances in single-cell analysis have enabled the delineation of distinct cellular states of brain tumor cells, but the time-dependent changes in such states remain poorly understood. Here, we construct quantitative models of the time-dependent transcriptional variation of patient-derived glioblastoma (GBM) cells. We build the models by sampling and profiling barcoded GBM cells and their progeny over the course of 3 weeks and by fitting a mathematical model to estimate changes in GBM cell states and their growth rates. Our model suggests a hierarchical yet plastic organization of GBM, where the rates and patterns of cell state switching are partly patient-specific. Therapeutic interventions produce complex dynamic effects, including inhibition of specific states and altered differentiation. Our method provides a general strategy to uncover time-dependent changes in cancer cells and offers a way to evaluate and predict how therapy affects cell state composition.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Syst Biol Asunto de la revista: BIOLOGIA MOLECULAR / BIOTECNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Syst Biol Asunto de la revista: BIOLOGIA MOLECULAR / BIOTECNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Suecia